B
Bettina Wedi
Researcher at Hannover Medical School
Publications - 205
Citations - 9503
Bettina Wedi is an academic researcher from Hannover Medical School. The author has contributed to research in topics: Medicine & Guideline. The author has an hindex of 35, co-authored 186 publications receiving 8198 citations. Previous affiliations of Bettina Wedi include Charité & Hochschule Hannover.
Papers
More filters
Journal ArticleDOI
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
Torsten Zuberbier,Werner Aberer,Riccardo Asero,Carsten Bindslev-Jensen,Zenon Brzoza,Giorgio Walter Canonica,Martin K. Church,Luis Felipe Ensina,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,A H Abdul Latiff,P. Mathelier-Fusade,Martin Metz,Alexander Nast,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,F. E. R. Simons,Petra Staubach,Gordon Sussman,Elias Toubi,Gino A. Vena,Bettina Wedi,X J Zhu,Markus Maurer +30 more
TL;DR: This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms, and outlines evidence-based diagnostic and therapeutic approaches for the different subtypes ofUrticaria.
Journal ArticleDOI
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
Torsten Zuberbier,Werner Aberer,Riccardo Asero,A H Abdul Latiff,Diane Baker,Barbara Ballmer-Weber,Jonathan A. Bernstein,Carsten Bindslev-Jensen,Zenon Brzoza,R Buense Bedrikow,G.W. Canonica,Martin K. Church,Timothy J. Craig,I V Danilycheva,Corinna Dressler,Luis Felipe Ensina,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,C. Katelaris,Emek Kocatürk,Kanokvalai Kulthanan,D. Larenas-Linnemann,Tabi A. Leslie,Markus Magerl,P. Mathelier-Fusade,R. Y. Meshkova,Martin Metz,Alexander Nast,Eustachio Nettis,Hanneke Oude-Elberink,Stefanie Rosumeck,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,Petra Staubach,Gordon Sussman,Elias Toubi,Gino A. Vena,Christian Vestergaard,Bettina Wedi,Ricardo Niklas Werner,Zuotao Zhao,Marcus Maurer +48 more
TL;DR: In this paper, an evidence-and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group.
Journal ArticleDOI
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.
T. Zuberbier,Riccardo Asero,Carsten Bindslev-Jensen,G. Walter Canonica,Martin K. Church,Ana Giménez-Arnau,Clive Grattan,Alexander Kapp,Hans F. Merk,Barbara Rogala,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,Holger J. Schünemann,Petra Staubach,Gino A. Vena,Bettina Wedi,Marcus Maurer +17 more
TL;DR: This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors, and pathomechanisms, and outlines evidence‐based diagnostic approaches for different subtypes ofUrticaria.
Journal ArticleDOI
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria.
Torsten Zuberbier,Riccardo Asero,Carsten Bindslev-Jensen,G. Walter Canonica,Martin K. Church,Ana Giménez-Arnau,Clive Grattan,Alexander Kapp,Marcus Maurer,Hans F. Merk,Barbara Rogala,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,Holger J. Schünemann,Petra Staubach,Gino A. Vena,Bettina Wedi +17 more
TL;DR: This guideline has a profound impact on the quality of life and effective treatment is, therefore, required and the recommended first line treatment is new generation, nonsedating H1‐antihistamines, and second‐line therapies should be added to the antihistamine treatment.
Journal ArticleDOI
EAACI/GA2LEN/EDF guideline: management of urticaria
T. Zuberbier,Carsten Bindslev-Jensen,Walter Canonica,Clive Grattan,Malcolm W. Greaves,Beate M. Henz,Alexander Kapp,M. M. A. Kozel,Marcus Maurer,Hans F. Merk,T. Schafer,Dagmar Simon,Gino A. Vena,Bettina Wedi +13 more
TL;DR: The recommended first line treatment are nonsedating H1 antihistamines, but dosages increased up to fourfold over the recommended doses may be necessary for different urticaria subtypes and in view of individual variation in the course of the disease and response to treatment.